دورية أكاديمية
أعرض في EDS

Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.

التفاصيل البيبلوغرافية
العنوان: Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
المؤلفون: Ikilezi G; Gates Ventures, Kirkland, WA, USA; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA., Micah AE; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA. Electronic address: amicah@uw.edu., Bachmeier SD; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA., Cogswell IE; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA., Maddison ER; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA., Stutzman HN; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA., Tsakalos G; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA., Brenzel L; Bill & Melinda Gates Foundation, Seattle, WA, USA., Dieleman JL; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
المصدر: Lancet (London, England) [Lancet] 2021 Nov 20; Vol. 398 (10314), pp. 1875-1893. Date of Electronic Publication: 2021 Nov 04.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
أسماء مطبوعة: Publication: 2004- : London : Elsevier
Original Publication: London : J. Onwhyn
مواضيع طبية MeSH: Developing Countries/*economics , Immunization/*economics, Child ; Child, Preschool ; Developing Countries/statistics & numerical data ; Financing, Government/economics ; Health Expenditures ; Healthcare Financing ; Humans ; Immunization/statistics & numerical data ; Immunization Programs/economics ; Infant ; International Agencies/economics ; Vaccines/economics
مستخلص: Background: Childhood immunisation is one of the most cost-effective health interventions. However, despite its known value, global access to vaccines remains far from complete. Although supply-side constraints lead to inadequate vaccine coverage in many health systems, there is no comprehensive analysis of the funding for immunisation. We aimed to fill this gap by generating estimates of funding for immunisation disaggregated by the source of funding and the type of activities in order to highlight the funding landscape for immunisation and inform policy making.
Methods: For this financial modelling study, we estimated annual spending on immunisations for 135 low-income and middle-income countries (as determined by the World Bank) from 2000 to 2017, with a focus on government, donor, and out-of-pocket spending, and disaggregated spending for vaccines and delivery costs, and routine schedules and supplementary campaigns. To generate these estimates, we extracted data from National Health Accounts, the WHO-UNICEF Joint Reporting Forms, comprehensive multi-year plans, databases from Gavi, the Vaccine Alliance, and the Institute for Health Metrics and Evaluation's 2019 development assistance for health database. We estimated total spending on immunisation by aggregating the government, donor, prepaid private, and household spending estimates.
Findings: Between 2000 and 2017, funding for immunisation totalled US$112·4 billion (95% uncertainty interval 108·5-118·5). Aggregated across all low-income and middle-income countries, government spending consistently remained the largest source of funding, providing between 60·0% (57·7-61·9) and 79·3% (73·8-81·4) of total immunisation spending each year (corresponding to between $2·5 billion [2·3-2·8] and $6·4 billion [6·0-7·0] each year). Across income groups, immunisation spending per surviving infant was similar in low-income and lower-middle-income countries and territories, with average spending of $40 (38-42) in low-income countries and $42 (39-46) in lower-middle-income countries, in 2017. In low-income countries and territories, development assistance made up the largest share of total immunisation spending (69·4% [64·6-72·0]; $630·2 million) in 2017. Across the 135 countries, we observed higher vaccine coverage and increased government spending on immunisation over time, although in some countries, predominantly in Latin America and the Caribbean and in sub-Saharan Africa, vaccine coverage decreased over time, while spending increased.
Interpretation: These estimates highlight the progress over the past two decades in increasing spending on immunisation. However, many challenges still remain and will require dedication and commitment to ensure that the progress made in the previous decade is sustained and advanced in the next decade for the Immunization Agenda 2030.
Funding: Bill & Melinda Gates Foundation.
Competing Interests: Declaration of interests We declare no competing interests.
(Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
التعليقات: Comment in: Lancet. 2021 Nov 20;398(10314):1852-1853. (PMID: 34742370)
References: Lancet Infect Dis. 2020 Aug;20(8):929-942. (PMID: 32334658)
Lancet. 2021 Aug 7;398(10299):503-521. (PMID: 34273291)
Open Forum Infect Dis. 2019 Mar 08;6(4):ofz117. (PMID: 31049363)
Pharmacoeconomics. 2005;23(4):333-43. (PMID: 15853434)
JAMA. 2019 Oct 1;322(13):1251-1252. (PMID: 31503276)
Lancet. 2020 Oct 17;396(10258):1204-1222. (PMID: 33069326)
Health Aff (Millwood). 2020 Aug;39(8):1343-1353. (PMID: 32744930)
Health Aff (Millwood). 2016 Feb;35(2):199-207. (PMID: 26858370)
Lancet Infect Dis. 2019 Jul;19(7):703-716. (PMID: 31036511)
Cost Eff Resour Alloc. 2015 Aug 20;13:14. (PMID: 26300696)
Lancet. 2021 Jan 30;397(10272):398-408. (PMID: 33516338)
المشرفين على المادة: 0 (Vaccines)
تواريخ الأحداث: Date Created: 20211107 Date Completed: 20220104 Latest Revision: 20220223
رمز التحديث: 20240513
مُعرف محوري في PubMed: PMC8844562
DOI: 10.1016/S0140-6736(21)01591-9
PMID: 34742369
قاعدة البيانات: MEDLINE
الوصف
تدمد:1474-547X
DOI:10.1016/S0140-6736(21)01591-9